These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12162600)

  • 1. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia.
    Shama A; Patole SK; Whitehall JS
    Acta Paediatr; 2002; 91(6):670-3. PubMed ID: 12162600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.
    Tan TQ; Mason EO; Ou CN; Kaplan SL
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2401-6. PubMed ID: 8285624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates.
    van der Lugt NM; Steggerda SJ; Walther FJ
    BMC Pediatr; 2010 Nov; 10():84. PubMed ID: 21092087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of vancomycin and rifampicin for the treatment of persistent coagulase-negative staphylococcal bacteremia in preterm neonates.
    Rodriguez-Guerineau L; Salvia-Roigés MD; León-Lozano M; Rodríguez-Miguélez JM; Figueras-Aloy J
    Eur J Pediatr; 2013 May; 172(5):693-7. PubMed ID: 23328960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates.
    Gkentzi D; Kolyva S; Spiliopoulou I; Marangos M; Dimitriou G
    Curr Pediatr Rev; 2016; 12(3):199-208. PubMed ID: 27262336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit.
    Khashu M; Osiovich H; Henry D; Al Khotani A; Solimano A; Speert DP
    Pediatrics; 2006 Feb; 117(2):340-8. PubMed ID: 16452352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
    Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
    Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous rifampicin for persistent staphylococcal bacteremia in premature infants.
    Soraisham AS; Al-Hindi MY
    Pediatr Int; 2008 Feb; 50(1):124-6. PubMed ID: 18279222
    [No Abstract]   [Full Text] [Related]  

  • 9. Persistent bacteremia and outcome in late onset infection among infants in a neonatal intensive care unit.
    Chapman RL; Faix RG
    Pediatr Infect Dis J; 2003 Jan; 22(1):17-21. PubMed ID: 12544403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response.
    Klingenberg C; Aarag E; Rønnestad A; Sollid JE; Abrahamsen TG; Kjeldsen G; Flaegstad T
    Pediatr Infect Dis J; 2005 Sep; 24(9):817-22. PubMed ID: 16148849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness.
    Klingenberg C; Rønnestad A; Anderson AS; Abrahamsen TG; Zorman J; Villaruz A; Flaegstad T; Otto M; Sollid JE
    Clin Microbiol Infect; 2007 Nov; 13(11):1100-11. PubMed ID: 17850346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
    Thwaites GE; Scarborough M; Szubert A; Nsutebu E; Tilley R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS;
    Lancet; 2018 Feb; 391(10121):668-678. PubMed ID: 29249276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiological profile of persistent coagulase-negative staphylococcal bacteraemia in neonates.
    Dimitriou G; Fouzas S; Giormezis N; Giannakopoulos I; Tzifas S; Foka A; Anastassiou DE; Spiliopoulou I; Mantagos S
    Clin Microbiol Infect; 2011 Nov; 17(11):1684-90. PubMed ID: 21463392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection.
    Schrenzel J; Harbarth S; Schockmel G; Genné D; Bregenzer T; Flueckiger U; Petignat C; Jacobs F; Francioli P; Zimmerli W; Lew DP;
    Clin Infect Dis; 2004 Nov; 39(9):1285-92. PubMed ID: 15494904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal sepsis and meningitis due to Staphylococcus cohnii.
    Kaya IS; Gamberzade S; Toppare MF; Senses DA; Dilmen U; Kitapci F
    J Pak Med Assoc; 1996 Feb; 46(2):43-4. PubMed ID: 8683849
    [No Abstract]   [Full Text] [Related]  

  • 16. Rifampicin as an adjunct to vancomycin therapy in MRSA septicaemia in burns.
    Gang RK; Sanyal SC; Mokaddas E; Lari AR
    Burns; 1999 Nov; 25(7):640-4. PubMed ID: 10563691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose vancomycin prophylaxis reduces coagulase-negative staphylococcal bacteraemia in very low birthweight infants.
    Cooke RW; Nycyk JA; Okuonghuae H; Shah V; Damjanovic V; Hart CA
    J Hosp Infect; 1997 Dec; 37(4):297-303. PubMed ID: 9457607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt.
    Mashaly GE; El-Mahdy RH
    Ann Clin Microbiol Antimicrob; 2017 Sep; 16(1):63. PubMed ID: 28927452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context.
    Hope R; Blackburn RM; Verlander NQ; Johnson AP; Kearns A; Hill R; Hopkins S; Sheridan E; Livermore DM; ;
    J Antimicrob Chemother; 2013 Nov; 68(11):2641-7. PubMed ID: 23794604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.